文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

住院运动性横纹肌溶解患者的急性肾损伤

Acute Kidney Injury in Hospitalized Patients With Exertional Rhabdomyolysis.
PubMed 文献 · JAMA Netw Open · 2024-08-01
一句话结论住院运动性横纹肌溶解患者急性肾损伤发生率8.5%,血清CK水平与AKI风险无关,入院前使用NSAIDs或脱水可能与AKI发生相关。

这项回顾性队列研究纳入2009年1月1日至2019年12月31日期间在北加州Kaiser Permanente住院的3790例横纹肌溶解患者,经病历审核确认200例运动性横纹肌溶解(ERM)患者(平均[SD]年龄30.5[8.5]岁;145例[72.5%]男性)。17例(8.5%)发生急性肾损伤(AKI),无慢性肾脏病(CKD)发生,1例(0.5%)发生骨筋膜室综合征,无死亡。血清CK水平与AKI风险无关联;入院前使用非甾体抗炎药(NSAIDs)者AKI风险显著更高(AKI组17例中11例[64.7%] vs 无AKI组183例中40例[21.9%],P < .001),脱水者AKI风险显著更高(无AKI组183例中9例[52.9%] vs AKI组17例中9例[4.9%],P < .001)。分析提示消除入院前NSAIDs使用和脱水可使该人群潜在AKI风险降低92.6%(95%CI,85.7%-96.1%)。作者认为,血清CK升高单独不足以作为ERM患者AKI的指标,NSAIDs使用或脱水等并发危险因素可能与AKI发生相关。

要点

  • 住院ERM患者AKI发生率为8.5%(17/200),无CKD发生,骨筋膜室综合征0.5%(1/200),无死亡。
  • 血清CK水平与AKI风险无关联,血清CK升高单独不足以作为ERM患者AKI的指标。
  • 入院前使用NSAIDs者AKI比例显著更高:AKI组64.7%(11/17) vs 无AKI组21.9%(40/183),P < .001。
  • 脱水者AKI比例显著更高:无AKI组52.9%(9/183) vs AKI组4.9%(9/17),P < .001;原文两组数值标签存在矛盾。
  • 分析提示消除入院前NSAIDs使用和脱水可使该人群潜在AKI风险降低92.6%(95%CI,85.7%-96.1%)。

适用人群与场景

  • 2009年1月1日至2019年12月31日在北加州Kaiser Permanente住院、年龄18岁及以上、经病历审核确认的运动性横纹肌溶解(ERM)患者200例(平均[SD]年龄30.5[8.5]岁;145例[72.5%]男性)。
  • 初始通过电子筛查所有-cause横纹肌溶解住院患者,再经人工病历审核确认研究资格。

诊断标准与关键阈值

  • AKI和CKD的诊断采用KDIGO(Kidney Disease Improving Global Outcomes)标准,并经病历审核确认。

研究设计与关键结果

  • 回顾性队列研究,2009年至2019年北加州Kaiser Permanente住院横纹肌溶解患者3790例,经病历审核确认ERM 200例。
  • 17例(8.5%)发生AKI,无CKD发生,1例(0.5%)发生骨筋膜室综合征,无死亡。
  • 血清CK水平与AKI风险无关联。
  • 入院前使用NSAIDs者AKI比例显著更高:AKI组17例中11例(64.7%) vs 无AKI组183例中40例(21.9%),P < .001。
  • 脱水者AKI比例显著更高:无AKI组183例中9例(52.9%) vs AKI组17例中9例(4.9%),P < .001;原文此处两组数值标签存在矛盾。
  • 分析提示消除入院前NSAIDs使用和脱水可使该人群潜在AKI风险降低92.6%(95%CI,85.7%-96.1%)。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,血清CK升高单独不足以作为ERM患者AKI的指标。
  • 作者认为,NSAIDs使用或脱水等并发危险因素可能与ERM患者AKI发生相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: An association between serum creatine kinase (CK) levels and the risk of kidney failure in patients with exertional rhabdomyolysis (ERM) has been suggested. However, the actual incidence of AKI in hospitalized patients with ERM along with the contributing cofactors that may increase the risk of AKI have rarely been investigated.

OBJECTIVES: To examine the incidence of kidney injury in hospitalized patients with ERM and to identify additional cofactors that might contribute to the development of kidney injury in patients with ERM.

DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study was conducted in a diverse community population of patients 18 years or older with ERM who were hospitalized across Kaiser Permanente Northern California between January 1, 2009, and December 31, 2019. Patients were initially identified through electronic screening for all-cause rhabdomyolysis admissions, followed by manual medical record reviews to verify their eligibility for the study. The diagnosis of AKI and chronic kidney disease (CKD) was determined using KDIGO (Kidney Disease Improving Global Outcomes) criteria and confirmed by medical record review. Data analysis was performed from October 1, 2023, to January 31, 2024.

EXPOSURES: History of strenuous physical exercise before hospitalization for ERM.

MAIN OUTCOME AND MEASURES: Development of AKI, CKD, and compartment syndrome and number of deaths.

RESULTS: Among 3790 patients hospitalized for rhabdomyolysis between 2009 and 2019 in Kaiser Permanente Northern California, 200 (mean [SD] age, 30.5 [8.5] years; 145 [72.5%] male) were confirmed to have ERM via medical record review. Seventeen patients (8.5%) developed AKI, none developed CKD, 1 (0.5%) developed compartment syndrome, and there were no fatalities. There was no association between serum CK levels and the risk of AKI. However, the risk of AKI was significantly higher in patients with ERM who used nonsteroidal anti-inflammatory drugs (NSAIDs) before admission (11 of 17 with AKI [64.7%] vs 40 of 183 without AKI [21.9%], P < .001) or experienced dehydration (9 of 183 without AKI [52.9%] vs 9 of 17 with AKI [4.9%], P < .001). This analysis suggests that eliminating preadmission NSAID use and dehydration could reduce the risk of potential AKI in patients with ERM by 92.6% (95% CI, 85.7%-96.1%) in this population.

CONCLUSIONS AND RELEVANCE: The findings of this cohort study of hospitalized patients with ERM suggest that serum CK elevation alone is insufficient as an indicator of AKI in patients with ERM. Concurrent risk factors, such as NSAID use or dehydration, may be associated with AKI development in patients with ERM.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Sabouri AH, Yurgionas B, Khorasani S, et al. Acute Kidney Injury in Hospitalized Patients With Exertional Rhabdomyolysis. JAMA Netw Open. 2024. PMID: 39136944. doi:10.1001/jamanetworkopen.2024.27464

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。